NCT05644418

Brief Summary

The goal of this clinical trial is to study the effects of Flow Controlled Ventilation (FCV) following conventional mechanical ventilation (Pressure or Volume Controlled Ventilation) in postcardiac surgery ICU-patients to allow for future power calculations and to obtain experience with FCV. The main questions it aims to answer are:

  • What is the effect of FCV on the lung volume measured by Electrical Impedance Tomography (EIT)?
  • What is the effect of FCV on the minute volume?
  • What is the effect of FCV on the mechanical power and dissipated energy? Participants will be ventilated with PCV at baseline and then switched to FCV for 90 minutes while the lung volume, minute volume and mechanical power and dissipated energy levels are measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 9, 2023

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

December 1, 2022

Last Update Submit

January 11, 2024

Conditions

Keywords

FCVEITMechanical PowerMinute volumeDissipated energyICU

Outcome Measures

Primary Outcomes (1)

  • End-expiratory lung volume

    The difference in End-expiratory lung volume (EELV) between PCV and FCV is measured using the difference in End-expiratory lung impedance (EELI) and tidal volume at baseline

    Baseline EELV compared to after 30 minutes of FCV (same ventilator settings)

Secondary Outcomes (3)

  • Minute volume

    The difference in minute volume between PCV at baseline and after 90 minutes of FCV (after optimization of FCV)

  • Mechanical Power

    The difference in Mechanical Power between PCV at baseline and after 90 minutes of FCV (after FCV optimization)

  • Dissipated energy

    The difference in Dissipated energy between PCV at baseline and after 90 minutes of FCV (after FCV optimization)

Study Arms (1)

Postcardiac surgery ICU-patients

EXPERIMENTAL

After postcardiac surgery patients are brought to the ICU and are ventilated on PCV (Pressure Controlled Ventilation). Measurements of the lung volume (by Electrical Impedance Tomography; EIT), the minute volume and Mechanical Power/Dissipated energy are started and continued for the duration of the study. After a few minutes the patient is switched to FCV (Flow Controlled Ventilation) for 90 minutes and afterwards PCV is resumed with the measurements lasting for another 30 minutes (total study time 120 minutes).

Device: Flow Controlled Ventilation (FCV)

Interventions

FCV is started with the same settings as PCV (PEEP, Ppeak, FiO2) and after 30 minutes FCV is optimized concerning the driving pressure and PEEP using the dynamic compliance. After a total of 60 minutes the flow is adjusted based on the arterial blood gas.

Postcardiac surgery ICU-patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older;
  • Informed consent form signed by the subject or a legal representative;
  • Controlled mechanical ventilation via an endotracheal tube -
  • FiO2 ≤50% and PEEP 10 cmH2O or lower

You may not qualify if:

  • Severe sputum stasis or production requiring frequent bronchial suctioning (more than 5 times per nurse shift)
  • Severe respiratory insufficiency defined as a PaO2 to FiO2 ratio of \<100mmHg or moderate to severe ARDS according to the Berlin definition of ARDS
  • Untreated pneumothorax (i.e. no pleural drainage)
  • Hemodynamic instability defined as a mean arterial pressure below 60mmHg not responding to fluids and/or vasopressors or a noradrenalin dose \>0.4mg/kg/min
  • Excessive subcutaneous emphysema (prevents proper functioning of the EIT device)
  • Thoracic wounds, bandages or other obstruction which prevent proper functioning of the EIT device
  • High (\>15 mmHg) or instable (an increase in sedation or osmotherapy is required) intracranial pressure
  • An inner tube diameter of 6mm or less

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus Medical Center

Rotterdam, South Holland, 3015 GD, Netherlands

Location

Related Publications (1)

  • Van Oosten JP, Francovich JE, Somhorst P, van der Zee P, Endeman H, Gommers DAMPJ, Jonkman AH. Flow-controlled ventilation decreases mechanical power in postoperative ICU patients. Intensive Care Med Exp. 2024 Mar 19;12(1):30. doi: 10.1186/s40635-024-00616-9.

Study Officials

  • Henrik Endeman, MD, PhD

    Erasmus MC, Rotterdam

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: PCV at baseline, followed by 90 minutes of FCV and finished with 30 minutes of PCV
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
H. Endeman, MD, PhD, Principle Investigator

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 9, 2022

Study Start

February 22, 2022

Primary Completion

May 9, 2023

Study Completion

May 9, 2023

Last Updated

January 12, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations